Difference between revisions of "Ultrasound CEUS BC"
Jump to navigation
Jump to search
| Line 19: | Line 19: | ||
*[[Media:01 12 2018 QIBA CEUS BC Call Summary-FINAL.pdf|01.12.2018 QIBA CEUS Biomarker Ctte Call Summary]] | *[[Media:01 12 2018 QIBA CEUS BC Call Summary-FINAL.pdf|01.12.2018 QIBA CEUS Biomarker Ctte Call Summary]] | ||
| − | |||
*[[Media:10 13 2017 QIBA CEUS BC Call Summary-FINAL.pdf|10.13.2017 QIBA CEUS Biomarker Ctte Call Summary]] | *[[Media:10 13 2017 QIBA CEUS BC Call Summary-FINAL.pdf|10.13.2017 QIBA CEUS Biomarker Ctte Call Summary]] | ||
*[[Media:09 22 2017 QIBA CEUS BC Call Summary-FINAL.pdf|09.22.2017 QIBA CEUS Biomarker Ctte Call Summary]] | *[[Media:09 22 2017 QIBA CEUS BC Call Summary-FINAL.pdf|09.22.2017 QIBA CEUS Biomarker Ctte Call Summary]] | ||
Revision as of 16:18, 18 January 2018
- Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD
- Secretary: Julie Lisiecki
Project Snapshot
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.
Project Descriptions:
CEUS Biomarker Committee Proposal:
Recent Meetings
Approved Call Summaries:
- 01.12.2018 QIBA CEUS Biomarker Ctte Call Summary
- 10.13.2017 QIBA CEUS Biomarker Ctte Call Summary
- 09.22.2017 QIBA CEUS Biomarker Ctte Call Summary
- 08.11.2017 QIBA CEUS Biomarker Ctte Call Summary
CEUS Task Force (TF) Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee:
Vendor Press Release:
Presentations: